It wasn’t just the lure of a 10-minute commute from his suburban Boston home that prompted John Reynders to join AstraZeneca (AZ) as head of R&D...

Over the years, Scientist has accumulated a lot of data about many aspects of the drug discovery and life science industry. It has always been a...

We are still offering webinars to users looking to take advantage of the tools Scientist has to offer, and now we are adding in Backoffice Hours...

When BioCurious opened its community laboratory in Sunnyvale, CA, last year, co-founder and chief architect Raymond McCauley only half-joked, “We...

The 2011-2012 school year is over, so we decided the next infographic should take a look at how the sciences are faring at schools in the United...

We’ve looked at what happens to a drug when a patent expires, but what happens to the patent owner? As patents have expired and many blockbuster...

Scientist was recently selected as a finalist for the 2012 Red Herring Top 100 Americas Award: SAN DIEGO — Scientist Inc., a global research...

Listen to an interview with Kevin Lustig, PhD on the Mendelspod podcast...

Ever since Amazon.com revolutionized online commerce in the 1990s by taking the traditional bookstore service to the Web, the world has seen an...

One doesn’t have to look far to find that the large pharmaceutical business model has many market forces working against it, such as patent...